Ebixa Pages on BioPortfolio:

BioPortfolio - Ebixa - Profile
10 Sep 2009 ... Ebixa is an effective, safe and well tolerated therapy, ... Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a ...
http://www.bioportfolio.com/biocorporate/22286-Ebixa.pdf...

Biotechnology News ESCITALOPRAM Search
... up 18% at constant exchange rates to 3.4 billion kroner as key drugs Cipralex (escitalopram; up 12% to 1.3 billion), Ebixa (memantine; up 18% to 539.
...
http://www.bioportfolio.co.uk/ESCITALOPRAM-news.htm...

BioPortfolio - Biocorporate Search VA
Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday ... Ebixa is indicated for... www.ebixa.com/ View full profile ...
http://www.bioportfolio.com/biocorporate/search/region/VA.ht...

BioPortfolio Bulletin - CNS Disorders Alzheimer's Disease Multiple ...
26 Oct 2004 ... This is largely due to the launch of Ebixa, the new NMDA receptor antagonist from Lundbeck/Forest, and the recognition by regulatory ...
http://www.bioportfolio.co.uk/bulletin_59.htm...

BioPortfolio Limited Alzheimer's Disease Market analysis and ...
3.3.4.1 Lundbeck Ebixa (Namenda) severe Alzheimer's disease clinical data 3.3. 4.2 Lundbeck Ebixa (Namenda) mild-to-moderate Alzheimer's disease clinical ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_86.html...

Alzheimer's Disease Market analysis and forecasts, 2007-2012, 2017 ...
NMDA receptor antagonist Mementine, marketed in the US by Forest as Nemanda and in EU as Ebixa by Lundbeck Mementine. However, all the listed drugs only ...
http://www.bioportfolio.com/cgi-bin/acatalog/Alzheimer_s_Dis...

BioPortfolio Limited Neurodegenerative Market Forecast to 2013 (TA222)
Namenda: also known as Ebixa in some EU countries; Ebixa: also known as Namenda in US. Other Alzheimer's Therapies Targeting Neurotransmitters ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_559.html...

BioPortfolio Limited Pipeline and Commercial Insight: Alzheimer's ...
NMDA receptor antagonist: memantine (Namenda/Ebixa/Axura) 44. CHAPTER 3 BRAND DYNAMICS AND LEADING COMPARATOR THERAPIES 45. Marketed brands overview 46 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_320.html...

BioPortfolio Client Press Releases Site Map
Merz and Lundbeck received European Union marketing approval for Ebixa ( Memantine) for the treatment of Alzheimers · Hormos Medical's novel male ...
http://www.bioportfolio.com/news/site_map.htm...

Results from other life science and pharmaceutical sites:

EbixaĀ® in Alzheimerā€™s disease
AzilectĀ® (rasagiline) is the first truly innovative therapy for Parkinsonā€™s disease to have been introduced in many years. AzilectĆ¢ is indicated for the
...
http://www.lundbeck.com/products/our_products/ebixa/default....

International Approvals: Ebixa, Depromel/Luvox, M-Vax
18 Oct 2005 ... The EU has approved an expanded indication for memantine HCl (Ebixa); Japan has approved a new indication for fluvoxamine maleate ...
http://www.medscape.com/viewarticle/514804...

Memantine (Ebixa) in clinical practice - results of an ...
Memantine (Ebixa) in clinical practice - results of an observational study. Calabrese P, Essner U, Forstl H. Neurologische Universitatsklinik Bochum ...
http://www.ncbi.nlm.nih.gov/pubmed/17622714...

Download presentation - Welcome to the homepage of H. Lundbeck A/S
Ebixa® now available for 80% of patients diagnosed with ... Ebixa® 8.4%. Other 1.8%. International Markets market share consists of Australia, Brazil, ...
http://www.lundbeck.com/investor/Presentations/Financial_pre...

A placebo-controlled study of memantine (Ebixa) in dementia of ...
A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke- Korsakoff syndrome. Rustembegović A, Kundurović Z, Sapcanin A, Sofic E. ...
http://www.ncbi.nlm.nih.gov/pubmed/12858653...

Lundbeck appoints new manager in China
Oscar Parra was in charge of launching Ebixa in Mexico, the first country in which ... Consequently, Oscar Parra has in-depth knowledge about Ebixa, ...
http://www.lundbeck.com/investor/releases/ReleaseDetails/Rel...

[Mémantine (Ebixa): a new therapeutic strategy for the treatment ...
Various preclinical studies have shown that memantine (Ebixa) inhibits glutaminergic hyperactivity in Alzheimer's disease through modulation of NMDA
...
http://www.ncbi.nlm.nih.gov/pubmed/15029079...

Slide 1 - Welcome to the homepage of H. Lundbeck A/S
2002 Ebixa®. 2009+ Lu 31-130. 2009+ Lu AA21004. 2005 Azilect® .... Ebixa® ( memantine) – the second most prescribed anti-alzheimer product ...
http://www.lundbeck.com/investor/Presentations/Financial_pre...

[Memantine (Ebixa), glutaminergic modulator]
[Memantine (Ebixa), glutaminergic modulator]. [Article in French]. Sternon J, Bier JC. Hôpital Erasme et CUMG-ULB, Bruxelles. ...
http://www.ncbi.nlm.nih.gov/pubmed/15157062...

Download presentation - Welcome to the homepage of H. Lundbeck A/S
15 Aug 2007 ... Ebixa® - Lundbecks second largest product ... Ebixa® available for patients diagnosed with moderate to severe Alzheimers Disease ...
http://www.lundbeck.com/investor/Presentations/Financial_pre...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.